$AEON Biopharma (AEON.US)$ coming off the watchlist. Company...

$AEON Biopharma (AEON.US)$ coming off the watchlist. Company has never turned a profit since it started (common enough for pharmaceutical R&D company like this), quarterly report seems to confirm their flagship product development is ineffective. Company will need to do some serious cap raising to stay afloat. Leave this one and take your money elsewhere.